BIVI insider trades & Congress trades
Biovie Inc.: public insider filings and Congress disclosures, in one place.
Bourse has recorded 4 open-market insider transactions in Biovie Inc. (BIVI) (4 purchases with code P and 0 sales with code S), the most recent on August 28, 2026.
In the last 90 days: 4 purchases by 4 insiders ($49K) and 0 sales by 0 ($0).
The most recent insider buying cluster (three or more different insiders buying within 14 days) ran from August 28, 2026 to August 28, 2026, with 3 insiders.
Insider transactions
SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.
| Date | Insider | Role | Type | Shares | Price | Value | After 1M |
|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | Kim Joanne Wendy | Chief Financial Officer | Buy | 2,500 | $2.18 | $5K | −0.3% |
| Aug 28, 2026 | Palumbo Joseph M | Chief Medical Officer | Buy | 4,843 | $2.16 | $10K | −0.3% |
| Aug 28, 2026 | Chappell Amy Suzon | – | Buy | 727 | $2.16 | $2K | −0.3% |
| Aug 27, 2026 | Do Cuong V | President & CEO | Buy | 15,210 | $2.08 | $32K | −0.3% |
Data as of November 8, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.
New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.
See these filings as they land
Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.
Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.